New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Centre National de la Recherche Scientifique · Aix-Marseille Université · +2 more institutions
Abstract
Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19) characterised by pulmonary infection in humans. The efforts of international health authorities have since focused on rapid diagnosis and isolation of patients as well as the search for therapies able to counter the most severe effects of the disease. In the absence of a known efficient therapy and because of the situation of a public-health emergency, it made sense to investigate the possible effect of…
Citation impact
- FWCI
- 27.36
- Percentile
- 100%
- References
- 113
Authors
4- CDChristian DevauxCorresponding
Centre National de la Recherche Scientifique, Aix-Marseille Université, Méditerranée Infection Foundation, Institut de Recherche pour le Développement
- JRJean‐Marc Rolain
Aix-Marseille Université, Méditerranée Infection Foundation, Institut de Recherche pour le Développement
- PCPhilippe Colson
Aix-Marseille Université, Méditerranée Infection Foundation, Institut de Recherche pour le Développement
- DRDidier Raoult
Aix-Marseille Université, Méditerranée Infection Foundation, Institut de Recherche pour le Développement
Topics & keywords
- Chloroquine
- Hydroxychloroquine
- Coronavirus
- Medicine
- Coronavirus disease 2019 (COVID-19)
- Repurposing
- Pandemic
- Drug repositioning
- Good health and well-being